Bank of America upped its price target for Vertex Pharmaceuticals from $555 to $567, signaling growing confidence in the ...

Leerink Partners analyst David Resinger warned his clients on Sunday that the tariff risks to the industry are ...

Vertex’s effort to provide fertility support services to those on government insurance programs who want to take the ...

Vertex Pharmaceuticals (VRTX) is the second stock to buy for the Nasdaq 100 correction. The biotech stock offers stability ...

Despite a $400 million impairment charge, analysts say the removal of a drug-device combo from its portfolio is not a huge ...